When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Cegueira noturna

Last reviewed: 20 Aug 2025
Last updated: 05 Sep 2023

Summary

Definition

History and exam

Key diagnostic factors

  • presença de fatores de risco
  • história familiar de perda da visão
  • história médica pregressa de deficiência de vitamina A (retinol) ou malignidade
Полная информация

Другие диагностические факторы

  • acuidade visual reduzida em luz fraca
  • respostas pupilares variáveis (dependendo da causa subjacente)
  • atenuação vascular retiniana
  • perda de campo visual
  • degeneração coriorretiniana periférica
  • história de medicamentos que interferem no metabolismo da vitamina A (retinol)
Полная информация

Факторы риска

  • retinite pigmentosa
  • cegueira noturna congênita estacionária
  • deficiência de vitamina A (retinol)
  • retinopatia associada ao câncer
  • retinopatia associada ao melanoma
  • atrofia girata
  • coroideremia
Полная информация

Диагностические исследования

Исследования, которые показаны в первую очередь

  • eletrorretinografia (ERG)
  • biomicroscopia de fenda e oftalmoscopia indireta
Полная информация

Исследования, проведение которых нужно рассмотреть

  • nível sérico de vitamina A (retinol)
  • sequenciamento de próxima geração
Полная информация

Алгоритм лечения

Острый

cegueira noturna genética

cegueira noturna adquirida

Составители

Авторы

Jonathan Smith, FRCOphth, MRCP

Consultant Ophthalmologist

Sunderland Eye Infirmary

Sunderland

UK

Раскрытие информации

JS has received sponsorship from Novartis, Bayer, and DORC for meeting travel and accommodation. JS was awarded a research grant in 2017 by the British Vitreoretinal Society.

Muhammad Raza Cheema, MRCGP, MRes, FRCOphth, FEBO

Specialist Registrar

Ophthalmology

Sunderland Eye Infirmary

Sunderland

UK

Раскрытие информации

MRC declares that he has no competing interests.

Wendy Adams, MRCP, FRCOphth

Consultant Ophthalmologist

Sunderland Eye Infirmary

Sunderland

UK

Раскрытие информации

WA declares that she has no competing interests.

Выражение благодарностей

Dr Jonathan Smith, Dr Wendy Adams, and Dr Muhammad Raza Cheema would like to gratefully acknowledge the assistance of Ms Karen Bradshaw. KB declares that she has no competing interests.

Рецензенты

Makoto Nakamura, MD

Associate Professor

Department of Ophthalmology

Nagoya University Graduate School of Medicine

Nagoya

Japan

Раскрытие информации

MN declares that he has no competing interests.

Eric Amesbury, MD

Klara Spinks Fleming Fellow

Jules Stein Eye Institute

UCLA

Los Angeles

CA

Раскрытие информации

EA declares that he has no competing interests.

Creig S. Hoyt, MD

Emeritus Professor and Chairman

Department of Ophthalmology

University of California

San Francisco

CA

Раскрытие информации

CSH declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006 Nov 18;368(9549):1795-809. Аннотация

Petzold A, Plant GT. Clinical disorders affecting mesopic vision. Ophthalmic Physiol Opt. 2006 May;26(3):326-41. Аннотация

Goodwin P. Hereditary retinal disease. Curr Opin Ophthalmol. 2008 May;19(3):255-62. Аннотация

Law WC, Rando RR. The molecular basis of retinoic acid induced night blindness. Biochem Biophys Res Commun. 1989 Jun 15;161(2):825-9. Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности